-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients

Sponsor: Astellas Pharma US, Inc
Program: Product Theaters
Sunday, December 6, 2020: 11:00 AM-12:00 PM
A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients

Ramon V. Tiu, MD

Astellas Pharma US, Inc., Northbrook, IL
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>